{"id":"W3188660209","doi":"10.1007/s40273-021-01068-9","title":"Cost Effectiveness of Triplet Selinexor-Bortezomib-Dexamethasone (XVd) in Previously Treated Multiple Myeloma (MM) Based on Results from the Phase III BOSTON Trial","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Notre-Dame","funders":"Karyopharm Therapeutics","keywords":"Medicine; Bortezomib; Multiple myeloma; Dexamethasone; Internal medicine; Oncology; Pomalidomide; Progression-free survival; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006937157,0.0007023089,0.00100226,0.0007194675,0.0001553244,0.001473888,0.000610971,0.0007281625,0.003189924],"category_scores_gemma":[0.01633585,0.0002841983,0.003106535,0.0006814665,0.0003477318,0.001136512,0.0007078548,0.001530889,0.0001429098],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003126932,"about_ca_system_score_gemma":0.001535134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004331403,"about_ca_topic_score_gemma":0.003933908,"domain_scores_codex":[0.9963786,0.002786397,0.0001488081,0.0001747591,0.0003484435,0.0001629767],"domain_scores_gemma":[0.9950173,0.004120512,0.0003776942,0.0001081796,0.0001675629,0.0002087443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.09790581,0.001524105,0.01937453,0.001580715,0.004993621,0.0005301716,0.0001460719,0.7308792,0.002213186,0.01643374,0.004993731,0.1194251],"study_design_scores_gemma":[0.04055365,0.03456741,0.04582887,0.001557754,0.01334346,0.001081645,0.0004313233,0.8058348,0.004258621,0.03799883,0.01428921,0.0002544317],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9638548,0.01213644,0.006902738,0.003048542,0.0001903546,0.0007968149,0.003451854,0.00008665187,0.009531634],"genre_scores_gemma":[0.9958092,0.001107308,0.001373973,0.0002415335,0.00002047507,0.0001577298,0.0008688534,0.000008622385,0.0004124505],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006937157,"threshold_uncertainty_score":0.03668767,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08245124933852116,"score_gpt":0.3953296840196429,"score_spread":0.3128784346811218,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}